PòsterJunyHypercalcemia of malignancy (HM) is the most common cause of hypercalcemia in the dog. It has an incidence of 12,9%. Its importance in veterinary and human medicine, has encouraged scientific investigations in the field. The highest prevalence of HM is found in lymphoma, followed by apocrine gland anal sac adenocarcinoma (AGASACA), carcinoma, bone neoplasia, sarcoma, multiple myeloma (MM), leukemia and thymoma
BackgroundDevelopment of hypocalcemia after treatment of hyperparathyroidism results in increased co...
Apocrine gland anal sac adenocarcinoma (AGASACA) of the dog is a frequently invasive and metastatic ...
A 9 year old female spayed Golden Retriever was evaluated for abdominal discomfort and guarding afte...
Background: Paraneoplastic syndromes are complexes symptom that occur at a distinct site from the pr...
Hypercalemia of Malignancy is defined as a pathological rise in blood calcium in response to a malig...
Malignant hypercalcemia is a paraneoplastic syndrome. It has been detected in several types of malig...
Cancer-associated hypercalcemia (CAH) is a frequently-occurring paraneoplastic syndrome that contrib...
A 4-year-old, neutered male Golden Retriever was presented with a 1-week history of weight loss, pol...
Objective: Examine the clinical and biochemical features including serum intact PTH (iPTH) and plasm...
Hypercalcemia of malignancy (HM) is the most common metabolic disorder in cancer patients, represent...
Malignancy is one of the most common causes of hypercalcemia, particularly in cancer associated with...
Background: Parathyroid hormone (PTH) and parathyroid hormone-related protein (PTH-rP) are two poten...
Different mechanisms are responsible for hypercalcemia, enclosed: (1) degradation of bone matrix in ...
Calcium is essential for several human physiological processes, including the function of cellular m...
Hypercalcemia of malignancy is a common finding typically found in patients with advanced stage canc...
BackgroundDevelopment of hypocalcemia after treatment of hyperparathyroidism results in increased co...
Apocrine gland anal sac adenocarcinoma (AGASACA) of the dog is a frequently invasive and metastatic ...
A 9 year old female spayed Golden Retriever was evaluated for abdominal discomfort and guarding afte...
Background: Paraneoplastic syndromes are complexes symptom that occur at a distinct site from the pr...
Hypercalemia of Malignancy is defined as a pathological rise in blood calcium in response to a malig...
Malignant hypercalcemia is a paraneoplastic syndrome. It has been detected in several types of malig...
Cancer-associated hypercalcemia (CAH) is a frequently-occurring paraneoplastic syndrome that contrib...
A 4-year-old, neutered male Golden Retriever was presented with a 1-week history of weight loss, pol...
Objective: Examine the clinical and biochemical features including serum intact PTH (iPTH) and plasm...
Hypercalcemia of malignancy (HM) is the most common metabolic disorder in cancer patients, represent...
Malignancy is one of the most common causes of hypercalcemia, particularly in cancer associated with...
Background: Parathyroid hormone (PTH) and parathyroid hormone-related protein (PTH-rP) are two poten...
Different mechanisms are responsible for hypercalcemia, enclosed: (1) degradation of bone matrix in ...
Calcium is essential for several human physiological processes, including the function of cellular m...
Hypercalcemia of malignancy is a common finding typically found in patients with advanced stage canc...
BackgroundDevelopment of hypocalcemia after treatment of hyperparathyroidism results in increased co...
Apocrine gland anal sac adenocarcinoma (AGASACA) of the dog is a frequently invasive and metastatic ...
A 9 year old female spayed Golden Retriever was evaluated for abdominal discomfort and guarding afte...